{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:27:24Z","timestamp":1785403644652,"version":"3.56.0"},"reference-count":15,"publisher":"Royal College of Psychiatrists","issue":"4","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["BJPsych open"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Psychedelics were used for centuries in healing and spiritual rituals, long before the mid-20th century when they became subjects of biomedical research. Although initial trials generated optimism, these were quickly overshadowed by sensationalist media coverage and political backlash. Following decades of inactivity, research on compounds including 3,4-methylenedioxymethamphetamine (MDMA) has resurged, along with the media attention. Investigating this growing interest, Bender et al employed a large-language model, validated against human raters, to analyse 25 years of media articles (2000\u20132025), quantifying trends in sentiment towards psychedelic therapies. Findings showed a dramatic increase in coverage,\u00a0with positive sentiment peaking in 2020 followed by a significant decline from 2024, coinciding with the U.S. Food and Drug Administration\u2019s decision not to approve MDMA-assisted therapy for post-traumatic stress disorder, and echoing the dynamics of the 1960s. The authors emphasise that sustained progress in the field will require reliance on scientific evidence to advance therapeutic applications.<\/jats:p>","DOI":"10.1192\/bjo.2026.12025","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:45:32Z","timestamp":1781768732000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Psychedelics, the media portrayal and large-language model evaluations"],"prefix":"10.1192","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9364-3974","authenticated-orcid":false,"given":"Catherine L.","family":"Clelland","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00hj8s172","id-type":"ROR","asserted-by":"publisher"}],"name":"Columbia University Irving Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"S2056472426120250_ref10","unstructured":"10 Dobin, R. Psychedelics can Change Humanity For the Better. It\u2019s Time to Unlock their Power. The Guardian, 2021 (https:\/\/www.theguardian.com\/commentisfree\/2021\/nov\/26\/psychedelics-can-change-humanity-for-the-better-its-time-to-unlock-their-power?CMP=share_btn_url)."},{"key":"S2056472426120250_ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206443"},{"key":"S2056472426120250_ref3","unstructured":"3 Brecher, EM and the Editors of Consumer Reports Magazine. The Consumers Union Report on Licit and Illicit Drugs. Schaffer Library of Drug Policy, 1972 (https:\/\/www.druglibrary.net\/schaffer\/Library\/studies\/cu\/CU50.html)."},{"key":"S2056472426120250_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101809"},{"key":"S2056472426120250_ref12","doi-asserted-by":"publisher","DOI":"10.1126\/science.ads4470"},{"key":"S2056472426120250_ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.14530"},{"key":"S2056472426120250_ref13","doi-asserted-by":"publisher","DOI":"10.37349\/edht.2024.00006"},{"key":"S2056472426120250_ref1","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2025.10974"},{"key":"S2056472426120250_ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.2546"},{"key":"S2056472426120250_ref2","doi-asserted-by":"publisher","DOI":"10.1177\/070674370505000703"},{"key":"S2056472426120250_ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950020022002"},{"key":"S2056472426120250_ref5","doi-asserted-by":"publisher","DOI":"10.1177\/02698811251371690"},{"key":"S2056472426120250_ref14","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.241776"},{"key":"S2056472426120250_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109426"},{"key":"S2056472426120250_ref9","unstructured":"9 Klein, E. Can Magic Mushrooms Heal Us? A Very Promising Mental Health Experiment is Taking Shape in Oregon. The New York Times, 2021 (https:\/\/www.nytimes.com\/2021\/03\/18\/opinion\/oregon-psychedelic-therapy.html?unlocked_article_code=1.OlA.UyqL.BotAfcaT952t&smid=url-share)."}],"container-title":["BJPsych Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2056472426120250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:45:37Z","timestamp":1781768737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2056472426120250\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["S2056472426120250"],"URL":"https:\/\/doi.org\/10.1192\/bjo.2026.12025","relation":{},"ISSN":["2056-4724"],"issn-type":[{"value":"2056-4724","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"\u00a9 The Author(s), 2026. Published by Cambridge University Press on behalf of Royal College of Psychiatrists","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided that no alterations are made and the original article is properly cited. The written permission of Cambridge University Press or the rights holder(s) must be obtained prior to any commercial use and\/or adaptation of the article.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e167"}}